These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7248753)

  • 1. beta-Endorphin-induced hyperglycemia is mediated by increased central sympathetic outflow to adrenal medulla.
    van Loon GH; Appel NM
    Brain Res; 1981 Jan; 204(1):236-41. PubMed ID: 7248753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-endorphin-induced increases in plasma epinephrine, norepinephrine and dopamine in rats: inhibition of adrenomedullary response by intracerebral somatostatin.
    Van Loon GR; Appel NM; Ho D
    Brain Res; 1981 May; 212(1):207-14. PubMed ID: 6112047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-Endorphin-induced stimulation of central sympathetic outflow: beta-endorphin increases plasma concentrations of epinephrine, norepinephrine, and dopamine in rats.
    Van Loon GR; Appel NM; Ho D
    Endocrinology; 1981 Jul; 109(1):46-53. PubMed ID: 6263592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Endorphin-induced stimulation of central sympathetic outflow: inhibitory modulation by central noradrenergic neurons.
    Appel NM; Van Loon GR
    J Pharmacol Exp Ther; 1986 Jun; 237(3):695-701. PubMed ID: 2940358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mu receptors at discrete hypothalamic and brainstem sites mediate opioid peptide-induced increases in central sympathetic outflow.
    Appel NM; Kiritsy-Roy JA; van Loon GR
    Brain Res; 1986 Jul; 378(1):8-20. PubMed ID: 3017504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Endorphin-induced increases in plasma dopamine, norepinephrine and epinephrine.
    Van Loon GR; Appel NM
    Res Commun Chem Pathol Pharmacol; 1980 Mar; 27(3):607-10. PubMed ID: 7384650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomic and endocrine participation in opioid peptide-induced hyperglycemia.
    Appel NM; Track NS; Van Loon GR
    J Auton Nerv Syst; 1987 Oct; 20(3):221-31. PubMed ID: 2826568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain beta-endorphin and other opioids are involved in restraint stress-induced stimulation of the hypothalamic-pituitary-adrenal axis, the sympathetic nervous system, and the adrenal medulla in the rat.
    Yamauchi N; Shibasaki T; Wakabayashi I; Demura H
    Brain Res; 1997 Nov; 777(1-2):140-6. PubMed ID: 9449422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoinsulinemic and hyperglycemic effects of beta-endorphin in rabbits.
    Knudtzon J
    Horm Metab Res; 1986 Aug; 18(8):505-9. PubMed ID: 2944808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of imidazoline receptors in adrenal gland to lower plasma glucose in streptozotocin-induced diabetic rats.
    Hwang SL; Liu IM; Tzeng TF; Cheng JT
    Diabetologia; 2005 Apr; 48(4):767-75. PubMed ID: 15756537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of angiotensin II receptors in brain potentiates the stimulating effect of endogenous opioid neurons on central sympathetic outflow.
    Appel NM; Van Loon GR
    Peptides; 1983; 4(1):59-62. PubMed ID: 6306616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-endorphin and the endocrine pancreas. Studies in healthy and diabetic human beings.
    Feldman M; Kiser RS; Unger RH; Li CH
    N Engl J Med; 1983 Feb; 308(7):349-53. PubMed ID: 6296674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic mediation of beta-endorphin-induced prolactin secretion.
    Van Loon GR; De Souza EB; Shin SH
    Neuroendocrinology; 1980 Oct; 31(4):293-6. PubMed ID: 6252497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase of beta-endorphin secretion by agmatine is induced by activation of imidazoline I(2A) receptors in adrenal gland of rats.
    Chang CH; Wu HT; Cheng KC; Lin HJ; Cheng JT
    Neurosci Lett; 2010 Jan; 468(3):297-9. PubMed ID: 19913596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that central dopamine receptors modulate sympathetic neuronal activity to the adrenal medulla to alter glucoregulatory mechanisms.
    Arnerić SP; Chow SA; Bhatnagar RK; Webb RL; Fischer LJ; Long JP
    Neuropharmacology; 1984 Feb; 23(2A):137-47. PubMed ID: 6371573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism for blockade of angiotensin subtype 1 receptors to lower plasma glucose in streptozotocin-induced diabetic rats.
    Chan P; Liu IM; Tzeng TF; Yang TL; Cheng JT
    Diabetes Obes Metab; 2007 Jan; 9(1):39-49. PubMed ID: 17199717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylactic shock: catecholamine actions in the responses to opioid antagonists.
    Amir S
    Prog Clin Biol Res; 1988; 264():265-74. PubMed ID: 2454493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma norepinephrine, epinephrine and dopamine responses to intracerebral administration of a met-enkephalin analog, D-ala2-met-enkephalinamide, in rats.
    Van Loon GR; Appel NM
    Neuroendocrinology; 1981 Sep; 33(3):153-7. PubMed ID: 6270584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antianaphylactic effect of naloxone in mice is mediated by increased central sympathetic outflow to sympathetic nerve endings and adrenal medulla.
    Amir S
    Brain Res; 1983 Sep; 274(1):180-3. PubMed ID: 6412966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative contribution of nervous system and hormones to CNS-mediated hyperglycemia is determined by the neurochemical specificity in the brain.
    Iguchi A; Kunoh Y; Gotoh M; Miura H; Uemura K; Tamagawa T; Sakamoto N
    Physiol Behav; 1991 Nov; 50(5):1019-25. PubMed ID: 1805263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.